£118.77

This is the most expensive it has ever been. Walk away.

£119 today · previous high £119 · all-time low £114

Elsevier Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies (Volume 1) (Breaking Tolerance to Antibody-Mediated Immunotherapy, Volume 1)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days · 72 data points (no recent data)

Historical
Generating forecast…
£118.77 £113.59 £114.72 £115.85 £116.98 £118.11 £119.24 25 July 2026 11 August 2026 29 August 2026 16 September 2026 04 October 2026
View at Amazon ↗

Price data last checked 19 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 72 days • 2 price levels

Days at Price
Current Price
20 days 52 days · current 0 13 26 39 52 £114 £119 Days at Price

Price Analysis

Most common price: £119 (52 days, 72.2%)

Price range: £114 - £119

Price levels: 2 different prices over 72 days

Description
Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents a description of the sensitizers used to overcome resistance to anti-EGFR targeted antibody therapies in cancer, including novel engineered antibody drugs and other sensitizers. The book gives insights into the landscape of anti-EGFR based cancer treatments, the challenges of targeted therapy, and a glimpse into the future of antibody therapy. It offers pertinent science information on strategies used for the rational design and discovery of novel sensitizing agents, and in addition, translational studies involving pre-clinical and clinical design. This book is an indispensable resource for cancer researchers, medicinal chemists and other biomedical scientists. Finally, the book covers basic science strategies used in drug discovery and preclinical evaluation focused on EGFR blockage resistance, as well as clinical trial methodology, including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new anticancer sensitizers for anti-EGFR drug resistance. Presents detailed descriptions on the history, chemistry, mechanism of action, structure-function relationships, pharmacology, side effects, dosing and formulation of new sensitizers to anti-EGFR antibodies Provides molecular structures for all novel anticancer drugs, along with strategies to overcome resistance to anti-EGFR antibodies Encompasses up-to-date information on the cancer drug discovery process, including new research tools, tumor-targeting strategies, and fundamental concepts in emerging areas of precision medicine

Product Specifications
Brand
Elsevier
Format
hardcover
ASIN
0128215844
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain
Amazon UK
Release Date
21 November 2022
Listed Since
30 October 2019

Barcode

No barcode data available

Similar Products You Might Like

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
97% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Elsevier

£117.40 24 Sep 2026
FIGHTING LUNG CANCER THROUGH THE HER FA (Cancer Etiology, Diagnosis and Treatments)
97% match

FIGHTING LUNG CANCER THROUGH THE HER FA (Cancer Etiology, Diagnosis and Treatments)

£86.82 13 Aug 2026
Side Effects of Medical Cancer Therapy: Prevention and Treatment
97% match

Side Effects of Medical Cancer Therapy: Prevention and Treatment

Springer

£105.51 07 Oct 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
97% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£88.21 12 Sep 2026
Handbook of Targeted Cancer Therapy and Immunotherapy
97% match

Handbook of Targeted Cancer Therapy and Immunotherapy

WOLTERS KLUWER HEALTH

£54.01 10 Sep 2026
Cancer Biology and Therapeutics
97% match

Cancer Biology and Therapeutics

Springer

£144.84 19 Aug 2026
Cancer Biology and Therapeutics
97% match

Cancer Biology and Therapeutics

Springer

£159.08 19 Sep 2026
Signaling Pathways and Molecular Mediators in Metastasis - Springer
97% match

Signaling Pathways and Molecular Mediators in Metastasis - Springer

Springer

£90.47 03 Oct 2026
Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)
97% match

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

IGI Global

£170.00 15 Aug 2026
Holland-Frei Cancer Medicine - Volume 1 and 2
97% match

Holland-Frei Cancer Medicine - Volume 1 and 2

Wiley

£137.02 11 Aug 2026
Drug Resistance in Cancer Cells
97% match

Drug Resistance in Cancer Cells

Springer

£111.44 30 Sep 2026
Advances in Cancer Research: 77: Volume 77
96% match

Advances in Cancer Research: 77: Volume 77

Elsevier

£93.97 23 Sep 2026
Abeloff's Clinical Oncology
96% match

Abeloff's Clinical Oncology

Elsevier

£227.94 21 Aug 2026
Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC (Volume 19) (Cancer Sensitizing Agents for Chemotherapy, Volume 19)
96% match

Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC (Volume 19) (Cancer Sensitizing Agents for Chemotherapy, Volume 19)

Elsevier

£135.99 01 Oct 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
96% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Elsevier

£120.98 22 Sep 2026
Cancer Chemotherapy: Basic Science to the Clinic
96% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley

£50.26 08 Sep 2026
Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies
96% match

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Elsevier

£131.39 20 Aug 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
96% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.67 18 Sep 2026
International Manual of Oncology Practice - iMOP Principles
96% match

International Manual of Oncology Practice - iMOP Principles

Springer

£127.65 07 Oct 2026
Evidence–Based Oncology (Evidence–Based Medicine)
96% match

Evidence–Based Oncology (Evidence–Based Medicine)

Wiley-Blackwell

£99.87 21 Aug 2026
Chemistry and Pharmacology of Anticancer Drugs - CRC Press
96% match

Chemistry and Pharmacology of Anticancer Drugs - CRC Press

CRC Press

£126.97 02 Oct 2026
Chemistry and Pharmacology of Anticancer Drugs
96% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£205.87 02 Oct 2026
Combination Cancer Therapy: Modulators and Potentiators Guide
96% match

Combination Cancer Therapy: Modulators and Potentiators Guide

Humana

£42.21 06 Oct 2026
Targeted Therapies in Oncology
96% match

Targeted Therapies in Oncology

CRC Press

£122.43 13 Oct 2026